the primary nationwide provider of services by creating diversified revenue streams that continue to provide cost-effective services and solutions that support the independent chronic kidney disease community to grow and thrive.
Join the webinar on October 24 for an introduction and review of the Mircera US products and its varied dosing of Q 2w and Q 4w dosing options for ESRD patients. Presented by Vifor Pharma.
215.320.4655 | firstname.lastname@example.org
6100 Oak Tree Blvd #200
Independence, OH 44131